![Andrew Marsh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Andrew Marsh
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andrew Marsh tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Human Resources Officer | |
NMD Pharma A/S
![]() NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Indalo Therapeutics, Inc.
![]() Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Avenge Bio, Inc.
![]() Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Founder | |
BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member | |
K36 Therapeutics, Inc.
![]() K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
Pulmatrix Operating Co., Inc.
![]() Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tufts University | College/University | Doctorate Degree | |
PULMATRIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Metera Pharmaceuticals, Inc.
![]() Metera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Metera Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Newton, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Vassar College | College/University | Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin | |
The Johns Hopkins University | College/University | Graduate Degree | |
TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman | |
NitroMed, Inc.
![]() NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Human Resources Officer | |
TYRX, Inc.
![]() TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Equipment/Instruments | Director/Board Member | |
University of Illinois | College/University | Graduate Degree | |
Cigna Holding Co.
![]() Cigna Holding Co. Life/Health InsuranceFinance Cigna Holding Co. engages in the provision of medical, dental, disability, life and accident insurance, and related products and services to businesses, governmental and non-governmental organizations, and individuals, through its subsidiaries. The company was founded in 1981 and is headquartered in Bloomfield, CT. | Life/Health Insurance | Human Resources Officer | |
Frito-Lay, Inc.
![]() Frito-Lay, Inc. Food: Specialty/CandyConsumer Non-Durables Part of PepsiCo, Inc., Frito-Lay, Inc. is a company that manufactures and sells corn and potato chips. The company is based in Wilmington, DE. | Food: Specialty/Candy | Corporate Officer/Principal | |
Boston Medical Center
![]() Boston Medical Center Hospital/Nursing ManagementHealth Services Boston Medical Center provides healthcare services. It provides a spectrum of pediatric and adult care services from primary to family medicine specialty care. The hospital is established in July 1996 and is headquartered in Boston, MA | Hospital/Nursing Management | Human Resources Officer | |
EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Onset Dermatologics LLC
![]() Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Onset Dermatologics LLC develops and markets prescription product for skin disorders. The company was founded in 2005 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Chief Executive Officer | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Connecticut | College/University | Undergraduate Degree | |
PreCision Dermatology, Inc.
![]() PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI. | Pharmaceuticals: Major | Founder | |
OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman | |
University of Michigan | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 35 |
Danimarca | 3 |
Settori
Health Technology | 25 |
Consumer Services | 8 |
Health Services | 3 |
Electronic Technology | 2 |
Finance | 2 |
Posizioni
Director/Board Member | 17 |
Independent Dir/Board Member | 12 |
Chairman | 7 |
Human Resources Officer | 5 |
Chief Executive Officer | 5 |
Contatti più connessi
Insiders | |
---|---|
Michael Heffernan | 23 |
Lisa Kelly-Croswell | 9 |
David L. Hava | 5 |
Daniel Rosan | 3 |
Jamie Austin | 3 |
- Borsa valori
- Insiders
- Andrew Marsh
- Connessioni Società